Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Allow: / Disallow: /terms-of-use Disallow: /privacy-policy Sitemap: https://www.to-be-determined.com/sitemap.xml |
Title | INFUGEM - Gemcitabine Hydrochloride in 0.9% Sodium Chloride |
Description | With ready-to-infuse INFUGEM™ premixed Learn more about the INFUGEM design. INFUGEM is engineered for practicality. Find out more here with links to our brochure and contact |
Keywords | Infugem data |
WebSite | infugem.com |
Host IP | 107.180.46.169 |
Location | United States |
Site | Rank |
US$1,335,235
Last updated: 2022-07-02 14:13:49
infugem.com has Semrush global rank of 7,926,926. infugem.com has an estimated worth of US$ 1,335,235, based on its estimated Ads revenue. infugem.com receives approximately 154,066 unique visitors each day. Its web server is located in United States, with IP address 107.180.46.169. According to SiteAdvisor, infugem.com is safe to visit. |
Purchase/Sale Value | US$1,335,235 |
Daily Ads Revenue | US$1,233 |
Monthly Ads Revenue | US$36,976 |
Yearly Ads Revenue | US$443,709 |
Daily Unique Visitors | 10,272 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
infugem.com. | A | 599 | IP: 107.180.46.169 |
infugem.com. | NS | 3600 | NS Record: ns35.domaincontrol.com. |
infugem.com. | NS | 3600 | NS Record: ns36.domaincontrol.com. |
Important Safety Information Prescribing Information HCPCS code J9198, 100 mg unit Contact a Rep For US healthcare professionals only HOME For US Healthcare Professionals Only INFUGEM™ Design Dosing Explore the Risks Access Resources Contact a Rep INFUGEM™ Design Dosing Explore The Risks Access Resources Contact a Rep Important Safety Information Prescribing Information HCPCS code J9198, 100 mg unit Contact Us With ready-to-infuse INFUGEM™ premixed gemcitabine You’re More Prepared Learn how INFUGEM reduces steps related to compounding and enhances processes that support you and your care team 1-6 INFUGEM is the first and only FDA-approved ready-to-infuse final dosage form of gemcitabine 1-3 INFUGEM is the first product using Sun’s proprietary technology delivering premixed final-dosage chemotherapies INFUGEM responds to the needs of your environment INFUGEM delivers a ready-to-infuse formulation of gemcitabine in 10 SKUs 3 INFUGEM eliminates steps in the preparation process, thereby |
HTTP/1.1 200 OK Date: Wed, 27 Oct 2021 22:39:41 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Mon, 20 Jul 2020 16:44:24 GMT ETag: "7502a37-42c13-5aae2381ad7ec" Accept-Ranges: bytes Content-Length: 273427 Vary: Accept-Encoding Content-Type: text/html |
Domain Name: INFUGEM.COM Registry Domain ID: 2034925478_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-30T16:05:38Z Creation Date: 2016-06-10T23:58:58Z Registry Expiry Date: 2023-07-30T11:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS35.DOMAINCONTROL.COM Name Server: NS36.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T17:50:37Z <<< |